News Ocrelizumab Linked to Improved Visual Outcomes in Relapsing MS by Medscape • 2017/10/27 • 0 Comments In pooled analysis from the phase 3 OPERA trials, low-contrast letter acuity showed improved visual outcomes in MS after treatment with ocrelizumab over interferon beta-1a. Medscape Medical News Full Story →